Seegene Venture Capital
1 known investors
Seegene develops molecular diagnostics platforms combining high-multiplex chemistry, AI-powered assay development, and automated modular systems for disease detection. The company serves global healthcare partners and diagnostic laboratories through a technology-sharing initiative that enables co-development and access to advanced diagnostics across multiple disease areas.